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The transcriptional activator CIITA is the master regulator
of the expression of MHC class II genes. In addition to this
major role, we have found that CIITA exerts an important
inhibitory effect on the HTLV-2 replication, similar to our
previously decribed effect on the HIV-1 replication. This
inhibition is mediated by the N-terminal 1–321 region
where we identified a minimal fragment of 80 aminoacids
that specifically blocks the activity of the viral transactiva-
tor Tax2. This fragment does not inhibit the function of
Tat, the transcriptional activator of HIV-1.
To unveil the biochemical basis of the CIITA-mediated
inhibition of Tax2 we first focussed on the identification
of the cellular cofactors used by Tax2 to transactivate the
viral promoter. DNA-binding factors (CREB, NFYB) and
several co-activators involved in chromatin remodeling
(CBP, p300, PCAF, BRG1) are known to interact with or
stimulate the transcriptional activity of both CIITA and
Tax1, the HTLV-1 homologous of Tax2. Preliminary data
indicate that the transactivation activity of Tax1 and Tax2
is differently influenced by the hystone acetyltransferases
CBP, p300 and PCAF providing new informations on the
biology of HTLV-2. Furthermore, none of these factors
was able to reverse the inhibitory action of CIITA on Tax2
function. Interestingly, we found that the B and, to a lesser
extent, the A subunits of the NFY complex inhibit Tax2
activity when iper-expressed in cells. On the basis of our
results and of the reported physical interactions between
NFY and both CIITA and Tax1, we propose a molecular
model for the CIITA-mediated inhibition of Tax2 activity
via the binding of the CIITA-NFY complex to Tax2. When
expressed in cells CIITA interacts with the NFY complex;
this interaction changes the conformation of NFY increas-
ing its binding affinity for Tax2. Following this model the
inhibition of Tax2 by CIITA it is not due to the squelching
of a transcriptional positive co-activator, but instead to
the recruitment of a cellular factor, NFY, with a negative
regulatory action on Tax2. This as well as possible alterna-
tive models are presently under scrutiny.
On the whole these results confirm that CIITA may repre-
sent a physiologic tool for novel therapeutic strategies
aimed at counteracting HLTV-2 replication and spreading.
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